Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Apellis Pharmaceuticals sell KongVestor

Start price
€54.00
23.12.23 / 50%
Target price
-
23.12.24
Performance (%)
-1.85%
End price
€53.00
06.01.24
Summary
This prediction ended on 06.01.24 with a price of €53.00. With a performance of -1.85%, the SELL prediction for Apellis Pharmaceuticals by KongVestor was down slightly. KongVestor has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Apellis Pharmaceuticals - -
iShares Core DAX® 2.831% 1.236%
iShares Nasdaq 100 2.918% 0.640%
iShares Nikkei 225® 2.007% -2.135%
iShares S&P 500 2.257% 0.451%

Comments by KongVestor for this prediction

In the thread Apellis Pharmaceuticals diskutieren

Sell Apellis Pharmaceuticals